pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›recall
recall
save

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall (Cls III)

November 20, 2024updated 5mo ago
community read0 votes

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61. — Reason: Failed Impurities/Degradation Specifications; during routine stability testing for impurities. — Status: Terminated

view source ↗
Data sources
fda recalls
last refreshed 34m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • approvalRALDESY (TRAZODONE HYDROCHLORIDE) — FDA approvalNov 26, 2024
  • approvalMORPHINE SULFATE — FDA approvalOct 31, 2024
  • approvalMORPHINE SULFATE — FDA approvalOct 31, 2024
  • approvalMORPHINE SULFATE — FDA approvalOct 31, 2024
  • approvalMORPHINE SULFATE — FDA approvalOct 31, 2024
  • approvalVIGABATRIN — FDA approvalDec 17, 2024

🐶 often sniffed alongside

top 8
  • tagRecall26 co-mentions · 19 sources
  • tagDrug Shortage9 co-mentions · 9 sources
  • drugprazosin hydrochloride6 co-mentions · 3 sources
  • drugISOTRETINOIN4 co-mentions · 2 sources
  • drugAbsorica4 co-mentions · 2 sources
  • drugmetoprolol succinate SR4 co-mentions · 4 sources
  • drugmetoprolol succinate ER4 co-mentions · 4 sources
  • drugZENATANE4 co-mentions · 2 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?